Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

Published-on by Indian Scientist

Mr. Akash Vikal | Nanotechnology and Advanced Materials | Innovative Research Award

IFTM University, Moradabad, India

Akash Vikal is an emerging pharmaceutical researcher specializing in pharmaceutics, nanomedicine, advanced drug delivery systems, and cancer therapeutics. His academic and research contributions primarily focus on the development of innovative formulation strategies designed to improve therapeutic efficacy, targeted delivery, and patient outcomes. Through extensive research in liposomal formulations, nanocarriers, gene delivery systems, and ocular therapeutics, he has established himself as a promising young contributor to modern pharmaceutical sciences.His research portfolio reflects interdisciplinary expertise integrating pharmaceutical technology, nanotechnology, oncology, ophthalmic therapeutics, and translational medicine. With numerous peer-reviewed publications, book chapters, and scientific presentations, he has actively contributed to advancing pharmaceutical innovation and drug delivery research.

Professional Profile 

Education

Akash Vikal completed a Bachelor of Pharmacy (B.Pharm.) from Shri Gopichand College of Pharmacy with strong academic performance. He further pursued a Master of Pharmacy (M.Pharm.) in Pharmaceutics from ISF College of Pharmacy, where he specialized in advanced pharmaceutical formulation and drug delivery systems. His postgraduate research focused on the “Development and Characterization of Ferulic Acid and Docetaxel Loaded Liposomes Against Breast Cancer” under the guidance of Balak Das Kurmi.

Professional Experience

During his academic journey, Akash Vikal gained industrial exposure through internship training at HIS Pharmaceuticals Pvt. Ltd., where he developed practical knowledge related to pharmaceutical manufacturing and formulation processes. He has also actively contributed to scientific communication and peer-review activities, including reviewing submissions for reputed journals such as Dovepress journals Clinical Ophthalmology and Eye and Brain. In addition, he delivered an academic webinar on scientific writing and publication strategies for researchers and healthcare professionals.

Research Interest

He has contributed extensively to pharmaceutical and biomedical research through numerous publications in reputed international journals. His research covers areas such as metal-organic frameworks in drug delivery, PROTAC-based cancer therapy, nanoparticle-mediated antimicrobial strategies, CRISPR-assisted nanotechnology, nanocarrier systems for ocular therapeutics, and phytoconstituent-based anticancer therapies. Several of his works have been published in recognized journals including Applied Materials Today, Drug Delivery and Translational Research, AAPS PharmSciTech, Current Pharmaceutical Design, and Experimental Eye Research.

Award and Honor

Akash Vikal has received recognition for his academic and scientific contributions through participation in national and international conferences, workshops, and faculty development programs. He earned a Certificate of Excellence in Peer Reviewing for his contribution to academic quality enhancement. His involvement in intellectual property awareness programs, pharmaceutical research conferences, and specialized training workshops reflects his commitment to continuous professional development and scientific advancement.

Conclusion

Mebratu Tafesse Teferi demonstrates strong potential for the Best Researcher Award. His substantial academic qualifications, leadership experience, and dedication to educational research are commendable. His publications reflect significant contributions to Ethiopian education and leadership studies, making him a valuable candidate for the award. To further enhance his candidacy, Mebratu could focus on broadening his research scope, fostering international collaborations, and increasing his publication reach in globally recognized journals.

Publications Top Noted

  • Next-generation gene editing strategies in cancer: Integrating CRISPR, PROTACs, and advanced molecular technologies
    Authors: Akash Vikal, Rashmi Maurya, Pradeep Kumar, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • Liposomal Paclitaxel in Breast Cancer Therapy: Advances, Clinical Insights, and Future Perspectives
    Authors: Akash Vikal, Rashmi Maurya, Navneet Verma, Arun Kumar Mishra
    Year: 2026
  • A Mini-Review on Unlocking Cognitive Enhancement: An Innovative Strategy for Optimal Brain Functions
    Authors: Akash Vikal, Rashmi Maurya, Brij Bihari Patel, Preeti Patel, Manish Kumar, Balak Das Kurmi
    Year: 2025
  • Andrographis paniculata in Fatty Liver Disease: Mechanisms, Nanocarrier Approaches, and Therapeutic Potential
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Development of Mucopenetrating Pegylated Liposomes Functionalized with Sodium Taurocholate for Enhanced Oral Insulin Delivery
    Authors: Akash Vikal, Rashmi Maurya, Balak Das Kurmi, S. Jindal, R. K. Narang
    Year: 2025
  • From Resistance to Response: Metallic Nanoparticles as Game Changers in Triple Negative Breast Cancer Therapy
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, R. K. Narang, Balak Das Kurmi
    Year: 2025
  • Lutein as a Liver Guardian: Insights into its Hepatoprotective Mechanisms, Bioavailability, and Emerging Therapeutic Roles
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Nanoemulsion Technology in Oral Drug Delivery: A Path to Enhanced Solubility and Bioavailability
    Authors: Akash Vikal, Rashmi Maurya, Preeti Patel, Balak Das Kurmi
    Year: 2025
  • Role of dePEGylation in Vesicular Carriers-Mediated Stimuli-Responsive Drug Delivery to Tumors
    Authors: Akash Vikal, Rashmi Maurya, Abhinav Vashishat, Taqdir Singh, Satyam Khare, Preeti Patel, Balak Das Kurmi
    Year: 2025

 

Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

Published-on by Indian Scientist

Mr. Ashish Sriram Mishra | Pharmaceutics | Research Excellence Award

SRM College of Pharmacy SRMIST Kattankulathur Chennai | India

Mr. Ashish Sriram Mishra is a dedicated researcher in pharmaceutics with strong expertise in novel drug delivery systems, optimization tools, and formulation science, currently pursuing doctoral research at SRM Institute of Science and Technology. He has completed his postgraduate and undergraduate studies in pharmacy with excellent academic performance, building a solid foundation in biopharmaceutics, pharmacokinetics, and advanced pharmaceutical technology. His research focuses on polymeric nanoparticles, lipid-based carriers, targeted gastrointestinal delivery, stability-indicating analytical methods, and drug repurposing strategies. He has authored impactful scientific publications in reputed journals, contributing an h-index of 3, over 40 citations, and more than 10 documents indexed in leading scholarly databases. His work includes advancements in nanomedicine, inflammation management, analytical method development, and Alzheimer’s disease therapeutic strategies. He has hands-on experience in formulation development, characterization techniques, cell studies, microbial assays, instrumental analysis, and design-based optimization, along with proficiency in scientific writing and laboratory documentation. His contributions to pharmaceutics reflect innovation, precision, and a commitment to translational research. He continues to advance his scientific expertise through active research, scholarly publications, and participation in collaborative academic environments, aiming to contribute significantly to pharmaceutical innovation and therapeutic development.

Profile: Google Scholar 

Featured Publications

Mishra, A. S., Vasanthan, M., & Malliappan, S. P. (n.d.). Drug repurposing: A leading strategy for new threats and targets. ACS Pharmacology & Translational Science, 7(4), 915–932.

Mishra, A. S., Sugumaran, A., & Damodharan, N. (n.d.). Nanoparticulate delivery systems for the effective treatment of COPD. Annals of the Romanian Society for Cell Biology, 25(4), 13892–13904.

Mishra, A. S., & Vasanthan, M. (n.d.). Design and validation of a robust stability-indicating reversed-phase HPLC method for quantification of mesalamine in formulated drug products. BMC Chemistry, 19(1), 303.

Mishra, A. S., Vasanthan, M., & Pandey, C. (n.d.). Comparative in silico human and environmental hazard profiling of ulcerative colitis pharmaceuticals. Environmental Chemistry and Ecotoxicology.

Mishra, A. S., & Vasanthan, M. (n.d.). Ecofriendly analytical quality by design aided RP-HPLC method for the estimation of mesalamine: Greenness, blueness and whiteness appraisal. Microchemical Journal, Article

Abdus Samad | Pharmacy | Outstanding Scientist Award

Published-on by Indian Scientist

Dr. Abdus Samad | Pharmacy | Outstanding Scientist Award

Post Graduate Institute of Medical Education & Research, Chandigarh | India

Dr. Sahima Tabasum is an emerging Environmental Science researcher with expertise in nanomaterials, water purification, photocatalysis, and environmental remediation, supported by an h-index of 4, over 48 citations, and 10 indexed documents. She holds a Ph.D. in Environmental Sciences, where she focused on nano-structural modification of g-C3N4-based composites for pesticide mineralization and the development of continuous photocatalytic reactor systems. Her multidisciplinary training includes advanced material synthesis, wastewater treatment technologies, solid waste management, and water quality monitoring. Dr. Tabasum has gained research experience through academic and international environmental programs, contributing to nanomaterial-based pollutant degradation, biochar fabrication, membrane technologies, microplastic treatment, and molecularly imprinted polymer (MIP) systems for emerging contaminants such as PFAS, ammonia, and heavy metals. Her research interests span photocatalysis, polymer membranes, CO₂ conversion, energy generation, nanomaterial–pollutant interactions, and sustainable environmental technologies. She has been recognized with distinctions for poster presentations, project excellence, and prestigious Young Scientist–International Travel Support, along with contributions to conferences, workshops, and global sustainability dialogues. With active roles as a reviewer and editorial board member for reputed journals, she continues to advance sustainable materials, green catalytic systems, and innovative solutions for environmental challenges.

Profile: Google Scholar

Featured Publications

Samad, A., Sultana, Y., & Aqil, M. (2007). Liposomal drug delivery systems: An update review. Current Drug Delivery, 4(4), 297–305.
(Cited by: 1310)

Alam, M. I., Beg, S., Samad, A., Baboota, S., Kohli, K., Ali, J., Ahuja, A., & Akbar, M. (2010). Strategy for effective brain drug delivery. European Journal of Pharmaceutical Sciences, 40(5), 385–403.
(Cited by: 557)

Samad, A., Alam, M. I., & Saxena, K. (2009). Dendrimers: A class of polymers in nanotechnology for the delivery of active pharmaceuticals. Current Pharmaceutical Design, 15(25), 2958–2969.
(Cited by: 129)

Beg, S., Samad, A., Alam, M. I., & Nazish, I. (2011). Dendrimers as novel systems for delivery of neuropharmaceuticals to the brain. CNS & Neurological Disorders – Drug Targets, 10(6), 693–702.
(Cited by: 84)

Samad, A., Shams, M. S., Ullah, Z., Wais, M., Nazish, I., Sultana, Y., & Aqil, M. (2009). Status of herbal medicines in the treatment of diabetes: A review. Current Diabetes Reviews, 5(2), 102–111.
(Cited by: 78)

Archna Dhasmana | Nanobiotechnology | Best Researcher Award

Published-on by Indian Scientist

Assist. Prof. Dr. Archna Dhasmana | Nanobiotechnology | Best Researcher Award

School of Biosciences, Swami Rama Himalayan University | India

Dr. Archna Dhasmana is an accomplished academic and researcher specializing in Tissue Engineering, Nanobiotechnology, and Regenerative Medicine. Her research focuses on biomolecule and drug delivery systems, polymeric scaffolds, and smart biomaterials for tissue remodeling and cancer theranostics. With over 40 peer-reviewed publications in high-impact SCI and Scopus-indexed journals such as Scientific Reports, Biomedicines, Frontiers in Bioengineering and Biotechnology, and Nanoscale, her work demonstrates significant contributions to biomedical innovation. She has achieved an H-index of 13, i10-index of 15, and 918 citations, reflecting strong research impact.Dr. Dhasmana’s funded projects include pioneering studies in bioengineered grafts, biogenic nanoparticles, and green nanotechnology for sustainable biomedical applications. She has successfully led and co-led projects supported by DHR, Ministry of Health and Family Welfare (₹75 lakhs) and institutional research grants. Her interdisciplinary research integrates molecular biology, polymer science, and nano-engineering to design next-generation biocompatible materials.

Profile: Google Scholar

Featured Publications

Gupta, S. K., Mishra, N. C., & Dhasmana, A. (2017). Decellularization methods for scaffold fabrication. In Decellularized scaffolds and organogenesis: Methods and protocols (pp. 1–10).

Malik, S., Kishore, S., Dhasmana, A., Kumari, P., Mitra, T., Chaudhary, V., … (2023). A perspective review on microbial fuel cells in treatment and product recovery from wastewater. Water, 15(2), 316.

Bhattacharjee, R., Kumar, L., Mukerjee, N., Anand, U., Dhasmana, A., … (2022). The emergence of metal oxide nanoparticles (NPs) as a phytomedicine: A two-facet role in plant growth, nano-toxicity and anti-phyto-microbial activity. Biomedicine & Pharmacotherapy, 155, 113658.

Bhandari, G., Dhasmana, A., Chaudhary, P., Gupta, S., Gangola, S., Gupta, A., … (2023). A perspective review on green nanotechnology in agro-ecosystems: Opportunities for sustainable agricultural practices and environmental remediation. Agriculture, 13(3), 668.

Dhasmana, A., Singh, A., & Sagar, R. (2020). Biomedical grafts for tracheal tissue repairing and regeneration: Tracheal tissue engineering—An overview. Journal of Tissue Engineering and Regenerative Medicine, 14(1), 653–672.

Dharmalingam Kirubakaran | Pharmacology | Best Researcher Award

Published-on by Indian Scientist

Assist. Prof. Dr. Dharmalingam Kirubakaran | Pharmacology | Best Researcher Award

Saveetha University | India

Dr. D. Kirubakaran is an accomplished researcher and Assistant Professor in the Department of Pharmacology at Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai. He holds a B.Sc., M.Sc., M.Phil, and Ph.D. in Botany, with research focused on green synthesis of nanoparticles and their biomedical applications. With extensive expertise in phytochemistry, nanotechnology, in-vitro experimental studies, toxicology, and environmental studies, Dr. Kirubakaran has developed and characterized nanoparticles using advanced techniques including UV-Vis, FTIR, XRD, SEM, TEM, DLS, and EDAX. His research encompasses antibacterial, antioxidant, anti-inflammatory, anti-diabetic, anticancer, and anticholinergic activities, alongside environmental applications such as bioremediation and biodiversity conservation. Dr. Kirubakaran has published numerous research articles in high-impact SCI journals, contributed book chapters, and actively participated in national and international conferences. He has received the University Research Fellowship for his significant contributions to scientific research. Recognized for his innovative work, he has accumulated over 469 citations, an h-index of 13, and an i10-index of 14. His current research interests focus on biomedical nanomaterials, green chemistry, and sustainable therapeutic strategies, positioning him as a leading contributor in the intersection of nanoscience and pharmacology.

Profiles: Google Scholar

Featured Publications

Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., Rajkumar, M., & SenthilKumar, K. J. (2025). A comprehensive review on the green synthesis of nanoparticles: Advancements in biomedical and environmental applications. Biomedical Materials & Devices, 1–26.

Manimegalai, P., Selvam, K., Loganathan, S., Kirubakaran, D., Shivakumar, M. S., & others. (2024). Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata: Their characterizations and biological applications. Biomass Conversion and Biorefinery, 14(11), 12559–12574.

Kirubakaran, D., Selvam, K., Prakash, P., Shivakumar, M. S., & Rajkumar, M. (2023). In-vitro antioxidant, antidiabetic, anticholinergic activity of iron/copper nanoparticles synthesized using Strobilanthes cordifolia leaf extract. OpenNano, 14, 100188.

Rajkumar, M., Presley, S. I. D., Govindaraj, P., Kirubakaran, D., Farahim, F., Ali, T., … others. (2025). Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and cytotoxic activities. Scientific Reports, 15(1), 3931.

Kirubakaran, D., Bupesh, G., Wahid, J. B. A., Murugeswaran, R., Ramalingam, J., & others. (2025). Green synthesis of zinc oxide nanoparticles using Acmella caulirhiza leaf extract: Characterization and assessment of antibacterial, antioxidant, anti-inflammatory and hemolytic properties. Biomedical Materials & Devices, 1–22.

Bijesh Biswal | Cell Biology | Excellence in Research Award

Published-on by Indian Scientist

Dr. Bijesh Biswal | Cell Biology | Excellence in Research Award

National Institute of Technology Rourkela | India

Dr. Bijesh Kumar Biswal is an Associate Professor at the Cancer Drug Resistance Laboratory, Department of Life Science, National Institute of Technology Rourkela, India. He holds a Ph.D. in Cancer Biology from IIT Madras and has completed postdoctoral research at Rutgers University and Dartmouth College, USA. His research focuses on cancer biology, particularly transcriptional regulation, drug resistance mechanisms, and exosome-mediated drug delivery. Dr. Biswal has authored over 60 publications and has been cited more than 1,100 times, reflecting his significant contribution to the field. He has mentored 3 Ph.D. students and 15 Master’s students, with several ongoing research projects. His work has been recognized with awards such as the Best Faculty Advisor Award from NIT Rourkela and the Early Career Research Award from SERB, DST, New Delhi. Dr. Biswal is a life member of the Indian Association of Cancer Research and the Society of Biochemists India. His research continues to influence cancer therapeutics and drug resistance studies.

Profiles: Google Scholar | Orcid

Featured Publication

Tripathi, S. K., Panda, M., & Biswal, B. K. (2019). Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy. Food and Chemical Toxicology, 125, 566–582.

Tripathi, S. K., & Biswal, B. K. (2020). Piperlongumine, a potent anticancer phytotherapeutic: Perspectives on contemporary status and future possibilities as an anticancer agent. Pharmacological Research, 156, 104772.

Panda, M., Tripathi, S. K., & Biswal, B. K. (2021). SOX9: An emerging driving factor from cancer progression to drug resistance. Biochimica et Biophysica Acta (BBA) – Reviews on Cancer, 1875(2), 188517.

Panda, M., & Biswal, B. K. (2019). Cell signaling and cancer: A mechanistic insight into drug resistance. Molecular Biology Reports, 46(5), 5645–5659.

Mao, P., Hever-Jardine, M. P., Rahme, G. J., Yang, E., Tam, J., Kodali, A., Biswal, B., … (2013). Serine/threonine kinase 17A is a novel candidate for therapeutic targeting in glioblastoma. PLoS One, 8(11), e81803.